Holen Sie sich die Stockscreener-App
30.47
0.59%
-0.18
Handel nachbörslich:
30.47
Indivior Pharmaceuticals Inc Aktie (INDV) Neueste Nachrichten
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN
JPMorgan Chase & Co. Has $5.01 Million Holdings in Indivior PLC $INDV - marketbeat.com
Did Potential Jail Staffing Efficiencies From SUBLOCADE® Just Shift Indivior Pharmaceuticals' (INDV) Investment Narrative? - Sahm
Indivior Pharmaceuticals Inc. R (E7P.F) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
Down 12.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Indivior Pharmaceuticals Inc. (INDV) - MSN
What Indivior Pharmaceuticals (INDV)'s Prison Cost Model Findings Mean For Shareholders - Yahoo Finance
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - The Globe and Mail
Indivior Pharmaceuticals, Inc - Reuters
Ultragenyx Pharmaceutical Announces FDA Acceptance of UX016 IND - TradingView
New Cost Impact Model Highlights Potential Benefits of Monthly Injectable Buprenorphine - National Today
New Cost Model Shows Monthly Injectable Buprenorphine Can Reduce Staffing Burdens in Prisons - National Today
New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities - manilatimes.net
Monthly opioid addiction shot may cut jail staffing, model estimates - Stock Titan
Zacks.com spotlights Indivior, Ciena, and Ultra Clean as notable mentions - Bitget
Zacks.com featured highlights include Indivior, Ciena and Ultra Clean - Yahoo Finance
FOCUS-Drugmakers delay some European launches with a wary eye on Trump's pricing policies - Sahm
Indivior PLC (NASDAQ:INDV) Short Interest Up 21.7% in March - MarketBeat
Indivior: Still Attractive After FY25 Earnings Beat (NASDAQ:INDV) - Seeking Alpha
Is It Time To Reassess Indivior Pharmaceuticals (INDV) After Its 200% One Year Surge? - simplywall.st
Hennion & Walsh Asset Management Inc. Purchases 96,177 Shares of Indivior PLC $INDV - MarketBeat
If You Invested $1,000 in Indivior Pharmaceuticals Inc. (INDV) - Stock Titan
SG Americas Securities LLC Buys 363,829 Shares of Indivior PLC $INDV - MarketBeat
Indivior PLC (NASDAQ:INDV) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Levi & Korsinsky Reminds Indivior Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 1, 2024INDV - MarketScreener
Indivior (INDV) posts 2025 growth, SUBLOCADE gains and $400M buyback in 2026 proxy - Stock Titan
Suboxone Market Size Forecasts 2026-2033: Analyzing Industry - openPR.com
Indivior PLC Stock Faces Uncertainty Amid U.S. Domicile Shift and OUD Market Focus - AD HOC NEWS
Indivior Pharmaceuticals Inc (INDV) Shares Up 5.07% on Mar 25 - GuruFocus
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B (XLV:NYSEARCA) - Seeking Alpha
Down 12.9% Over the Past Month: Reasons to Consider Purchasing Indivior Pharmaceuticals Inc. (INDV) During the Decline - Bitget
FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug - TradingView
[SCHEDULE 13G] Indivior Pharmaceuticals, Inc. Passive Investment Disclosure (>5%) - Stock Titan
Indivior Pharmaceuticals to report Q4 earnings: What's in the cards? - MSN
A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Recent Share Price Weakness - Sahm
Implied volatility surging for Indivior Pharmaceuticals stock options - MSN
Indivior Pharmaceuticals Inc (INDV) Shares Gap Down to $29.44 on Mar 20 - GuruFocus
Indivior (NASDAQ:INDV) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat
Goldentree Asset Management LP Makes New Investment in Indivior PLC $INDV - MarketBeat
Indivior outlines 30% adjusted EBITDA growth target for 2026 with new $400M share repurchase program - MSN
Indivior Issues $500 Million Convertible Senior Notes Offering - TipRanks
[Form 4] Indivior Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Indivior Pharmaceuticals Raises $500 Million Via 0.625% Convertible Notes Due 2031 - TradingView
Indivior Pharmaceuticals Survey Reveals Gaps in Medications for Opioid Use Disorder in U.S. Jails and Prisons - Quiver Quantitative
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder - GlobeNewswire
Indivior plans $400M convertible senior notes offering - MSN
Indivior PLC $INDV Shares Acquired by Divisadero Street Capital Management LP - MarketBeat
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):